Two weeks after announcing it had withdrawn its application for a capital infusion from the Treasury Department, Hanmi Financial Corp. in Los Angeles said it has struck a deal for an infusion from a Korean firm.

The $3.9 billion-asset Hanmi said Monday that Leading Investment and Securities Co. Ltd., a Korean securities broker, would inject up to $11 million in the company in a common equity deal.

Initially, Leading would invest $6.9 million, buying 5 million shares of newly issued stock at $1.37 each and gaining a 9.9% stake in Hanmi. If regulators approved the deal, the investment firm would then increase its stake to 14.9% with an additional $4.1 million infusion at the same price per share.

Subscribe Now

Access to authoritative analysis and perspective and our data-driven report series.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.